Psychedelic substances present in nature have been used by humans across hundreds of years to produce mind-altering changes in thought, mood, and perception—changes we do not experience otherwise except rarely in dreams, religious exaltation, or psychosis. U.S. scientists were studying the practical and therapeutic uses for hallucinogens, including LSD and mescaline, in the 1950s and 1960s supplied by large manufacturers including Sandoz. But the government took steps to ban all human consumption of hallucinogens, and thus the research. By the 1970s, all human testing was stopped. Medical concerns were not the issue, the ban was motivated by social concerns, not the least of which were created by legendary researcher Timothy Leary, a psychologist who advocated free use of hallucinogens by all who desired. Nationwide, however, a cadre of scholars and researchers has persisted in pushing the federal government to again allow human testing and the moratorium has been lifted. The FDA has begun approving hallucinogenic research using human subjects. In these groundbreaking volumes, top researchers explain the testing and research underway to use—under the guidance of a trained provider—psychedelic substances for better physical and mental health.
Psychedelic Medicine [2 volumes]: New Evidence for Hallucinogenic Substances as Treatments
📄 Viewing lite version
Full site ›
Book Details
PublisherPraeger
ISBN / ASIN0275990230
ISBN-139780275990237
AvailabilityUsually ships in 24 hours
Sales Rank1,253,868
CategoryMedical
MarketplaceUnited States 🇺🇸
Description ▲
More Books in Medical
Short-Term Bioassays in the Analysis of Complex Enviro…
View
Regulating Medical Work: Formal and Informal Controls …
View
Research and Development in Mental Health: Theory, Fra…
View
The AHA Clinical Cardiac Consult (The 5-Minute Consult…
View
Brain Dopaminergic Systems: Imaging with Positron Tomo…
View
Imaging & Intervention in Cardiology (Developments in …
View
Nuclear Medicine Therapy
View
Breast Imaging (Breast Disease, 13)
View
Handbook of Systemic Drug Treatment in Dermatology
View